Eva Font

Eva Font is Start-up and Regulatory Director at Pivotal.

Articles by Eva Font

Clinical practice across the EU and the UK is broadly comparable, supported by shared scientific guidance and similar treatment frameworks. Credit: Stock.Adobe.com/donfiore.

One Strategy, Two Jurisdictions: Unlocking Efficiency Across EU CTR and UK Regulatory Reform

June 15th 2026

How sponsors can leverage both the EU Clinical Trials Regulation and UK’s reformed framework to achieve cost efficiencies, faster timelines, and stronger regulatory positioning.

Eva Font

Articles by Eva Font

One Strategy, Two Jurisdictions: Unlocking Efficiency Across EU CTR and UK Regulatory Reform

Latest Updated Articles

Trending on Applied Clinical Trials Online

Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda

Real-Time Continuous Trials Through the Lens of Risk-Based Quality Management: Why RBQM Is the Infrastructure RTCT Cannot Exist Without

What Needs to Happen Beyond the Clinical Trial Modernization Act

ACT Brief: Community Research Access, Trustworthy AI Assistants, and Individualized Gene Editing Guidance

ACT Brief: Community Trial Access Technology, RBQM Infrastructure, and Digital Clone Use Cases